Inventiva (IVA) Projected to Post Earnings on Wednesday

Inventiva (NASDAQ:IVA) is projected to issue its quarterly earnings data before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ($0.43) per share for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

Inventiva Trading Down 2.0 %

NASDAQ IVA opened at $2.88 on Monday. Inventiva has a one year low of $1.53 and a one year high of $3.98. The stock has a 50-day moving average of $2.63 and a 200 day moving average of $2.46.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on IVA. TD Cowen initiated coverage on shares of Inventiva in a research note on Friday, February 21st. They issued a “buy” rating and a $10.00 price target for the company. HC Wainwright restated a “buy” rating and issued a $13.00 target price on shares of Inventiva in a report on Thursday, January 30th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Inventiva has an average rating of “Moderate Buy” and an average target price of $12.60.

About Inventiva

Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI.